Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 523 Leukemia, Myeloid, Acute 499 Neoplasms 381 Carcinoma, Non-Small-Cell Lung 381 Pancreatic Neoplasms 329 Precursor Cell Lymphoblastic Leukemia-Lymphoma 319 Multiple Myeloma 312 Glioblastoma 311 Melanoma 310 Prostatic Neoplasms 293 Leukemia 289 Neoplasm Metastasis 284 Brain Neoplasms 277 Lymphoma 271 Lung Neoplasms 270 Recurrence 267 Ovarian Neoplasms 247 Colorectal Neoplasms 246 Lymphoma, Non-Hodgkin 242 Leukemia, Lymphocytic, Chronic, B-Cell 231 Glioma 209 Myelodysplastic Syndromes 208 Lymphoma, Large B-Cell, Diffuse 186 Carcinoma, Hepatocellular 173 Lymphoma, Follicular 167 Head and Neck Neoplasms 162 Hodgkin Disease 160 Lymphoma, Mantle-Cell 155 Burkitt Lymphoma 154 Sarcoma 150

Interventions

Saline Solution 1 Ringer's Lactate 1 Ofloxacin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × OTHER × Ear Neoplasms × Clear all

NCT00584155 2015-05-27

Protection From Cisplatin Ototoxicity by Lactated Ringers

University of Oklahoma

Phase 1 Withdrawn

Ear Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡